AAOMS Annual Meeting

Conference Coverage

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

FDA Alerts
FDA Alerts
FDA Approves New Option for Generalized Myasthenia Gravis
10/25/2017
The US Food and Drug Administration has expanded the approval of a drug to include patients with generalized myasthenia gravis.
10/25/2017
FDA Alerts
FDA Alerts
FDA Approves New Option for Generalized Myasthenia Gravis
10/25/2017
The US Food and Drug Administration has expanded the approval of a drug to include patients with generalized myasthenia gravis.
10/25/2017
FDA Alerts
FDA Alerts
FDA Approves New Option for Generalized Myasthenia Gravis
10/25/2017
The US Food and Drug Administration has expanded the approval of a drug to include patients with generalized myasthenia gravis.
10/25/2017
Diabetes Q&A
Diabetes Q&A
FDA Approves Once-Weekly Diabetes Option
10/23/2017
The FDA has approved a new once-weekly, extended-release option for the treatment of adults with type 2 diabetes and uncontrolled blood sugar levels.
10/23/2017
Diabetes Q&A
Diabetes Q&A
FDA Approves Once-Weekly Diabetes Option
10/23/2017
The FDA has approved a new once-weekly, extended-release option for the treatment of adults with type 2 diabetes and uncontrolled blood sugar levels.
10/23/2017
Diabetes Q&A
Diabetes Q&A
FDA Approves Once-Weekly Diabetes Option
10/23/2017
The FDA has approved a new once-weekly, extended-release option for the treatment of adults with type 2 diabetes and uncontrolled blood sugar levels.
10/23/2017
Herpes Zoster
Herpes Zoster
FDA Approves New Herpes Zoster Vaccine
10/23/2017
Based on the results of a clinical trial program, the FDA has approved a new option for the prevention of herpes zoster.
10/23/2017
Drug Therapy
Drug Therapy
FDA: New Indications For Simponi Aria Approved
10/23/2017
After clinical trials demonstrated its safety and efficacy, the US Food and Drug Administration approved Simponi Aria for 2 new indications in adult patients.
10/23/2017
neuropathy
neuropathy
FDA Approves Extended-Release Tablets for Neuropathic Pain
10/12/2017
The US Food and Drug Administration recently approved once-daily extended-release tablets for the management of 2 peripheral neuropathic pain conditions.
10/12/2017
neuropathy
neuropathy
FDA Approves Extended-Release Tablets for Neuropathic Pain
10/12/2017
The US Food and Drug Administration recently approved once-daily extended-release tablets for the management of 2 peripheral neuropathic pain conditions.
10/12/2017